GenSpera Inc. – “Immunotherapy in GenSpera’s Future”

NEW YORK, NY / ACCESSWIRE / June 8, 2015 / GenSpera Inc. (OTCQB:GNSZ) today published a new blog post on The Chairman’s Blog, written by the Company’s chief executive officer, Craig Dionne, Ph.D. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platf orm to share insights about their company and industry trends.

With the prevalence of immuno-oncology at this year’s ASCO meetings in Chicago, CEO Dr. Craig Dionne discusses his time at the conference and the opportunities for GenSpera with the significant future of immunotherapy. “The potential for combining mipsagargin with immunotherapeutic approaches has long been recognized and addressed during our conversations with potential corporate partners. In my opinion, the certain future of immunotherapy in oncology may substantially increase the potential value of mipsagargin across a wide spectrum of tumor types,” said Dr. Dionne. Read the full blog post from Dr. Dionne on TheChairmansBlog.com (http://www.thechairmansblog.com/genspera/craig-dionne/immunotherapy-gensperas-future/).

About GenSpera:

GenSpera Inc. is a San Antonio-based biotech company that unlocks conventional thinking to conceive, design, and develop cancer therapies. GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates within tumors. GenSpera’s lead drug candidate, mipsagargin, was granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in 2013 for evaluation in patients with hepatocellular carcinoma (liver cancer).

For additional information on GenSpera, visit www.genspera.com and connect on Twitter, LinkedIn, Facebook, YouTube and Google+.

About TheChairmansBlog.com:

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 429609